Patient Guide: A Trial to Learn How Safe AZD9550 is in People With or Without Type 2 Diabetes Who Are Overweight or Obese

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 15 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06151964
Status: 🟢 Enrolling Now
Condition: Non-alcoholic Steatohepatitis (NASH)
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 15 locations across the country.

Top locations include:
  • • Graz,
  • • Vienna,
  • • Surrey, British Columbia
  • • And 12 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Trial to Learn How Safe AZD9550 is in People With or Without Type 2 Diabetes Who Are Overweight or Obese - Join Clinical Trial NCTNCT06151964

How to Join This Clinical Trial - NCTNCT06151964

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Non-alcoholic Steatohepatitis (NASH). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-alcoholic Steatohepatitis (NASH). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-alcoholic Steatohepatitis (NASH)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06151964 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 15 locations. Find a study site near you:

Clinical Research Site

Graz, 8036 - Austria

Status: COMPLETED

Clinical Research Site

Vienna, 1090 - Austria

Status: COMPLETED

Clinical Research Site

Surrey, British Columbia V3T 2V6 - Canada

Status: RECRUITING

Clinical Research Site

Sarnia, Ontario N7T 4X3 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

Stouffville, Ontario L4A 1H2 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

Toronto, Ontario M4G 3E8 - Canada

Status: RECRUITING

Clinical Research Site

Toronto, Ontario M4J 5B9 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

Sherbrooke, Quebec J1L 0H8 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

Magdeburg, 39120 - Germany

Status: RECRUITING

Clinical Research Site

Neu-Ulm, 89231 - Germany

Status: RECRUITING

And 5 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Non-alcoholic Steatohepatitis (NASH):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships